MAZZAGLIA, GIAMPIERO
 Distribuzione geografica
Continente #
NA - Nord America 28.082
AS - Asia 16.260
EU - Europa 10.874
SA - Sud America 2.678
Continente sconosciuto - Info sul continente non disponibili 1.419
AF - Africa 339
OC - Oceania 25
Totale 59.677
Nazione #
US - Stati Uniti d'America 25.583
SG - Singapore 5.778
IT - Italia 3.830
VN - Vietnam 2.934
HK - Hong Kong 2.822
CN - Cina 2.529
BR - Brasile 2.097
CA - Canada 2.031
RU - Federazione Russa 1.918
IE - Irlanda 1.331
SE - Svezia 857
DE - Germania 803
FR - Francia 501
GB - Regno Unito 495
BD - Bangladesh 470
UA - Ucraina 453
IN - India 334
KR - Corea 263
AR - Argentina 241
ID - Indonesia 207
FI - Finlandia 181
IQ - Iraq 139
TR - Turchia 117
MX - Messico 112
NL - Olanda 109
ZA - Sudafrica 106
PK - Pakistan 93
EC - Ecuador 87
SA - Arabia Saudita 84
PH - Filippine 78
JP - Giappone 67
CO - Colombia 66
AT - Austria 61
CR - Costa Rica 57
PL - Polonia 57
ES - Italia 55
VE - Venezuela 51
UZ - Uzbekistan 49
MA - Marocco 43
MY - Malesia 43
JM - Giamaica 42
TT - Trinidad e Tobago 42
EG - Egitto 41
HN - Honduras 40
CL - Cile 39
CH - Svizzera 37
PY - Paraguay 37
BE - Belgio 35
GT - Guatemala 34
SV - El Salvador 31
NP - Nepal 29
KE - Kenya 28
PR - Porto Rico 27
JO - Giordania 26
TN - Tunisia 25
AU - Australia 24
NI - Nicaragua 24
PE - Perù 22
UY - Uruguay 22
CZ - Repubblica Ceca 20
IL - Israele 20
AE - Emirati Arabi Uniti 19
LB - Libano 19
DO - Repubblica Dominicana 18
TH - Thailandia 18
AL - Albania 16
DZ - Algeria 15
ET - Etiopia 15
IR - Iran 15
RO - Romania 15
KZ - Kazakistan 14
OM - Oman 14
CW - ???statistics.table.value.countryCode.CW??? 13
DK - Danimarca 13
AZ - Azerbaigian 12
BO - Bolivia 11
LT - Lituania 11
PT - Portogallo 11
NG - Nigeria 10
TW - Taiwan 10
PA - Panama 9
EU - Europa 8
GP - Guadalupe 8
LY - Libia 8
MU - Mauritius 8
NO - Norvegia 8
PS - Palestinian Territory 8
BB - Barbados 7
BH - Bahrain 7
CI - Costa d'Avorio 6
EE - Estonia 6
GR - Grecia 6
HU - Ungheria 6
KG - Kirghizistan 6
MD - Moldavia 6
AO - Angola 5
BG - Bulgaria 5
BY - Bielorussia 5
GY - Guiana 5
KW - Kuwait 5
Totale 58.178
Città #
Ashburn 3.142
Hong Kong 2.792
Singapore 2.630
Toronto 1.752
Fairfield 1.717
San Jose 1.382
Ann Arbor 1.324
Dublin 1.289
Houston 1.256
Milan 1.060
Council Bluffs 962
Woodbridge 889
Ho Chi Minh City 864
Santa Clara 774
New York 727
Seattle 683
Wilmington 663
Hanoi 648
Dearborn 639
Princeton 577
Cambridge 548
Chandler 493
Frankfurt am Main 479
Chicago 470
Rome 401
Dallas 396
The Dalles 388
Jacksonville 382
Los Angeles 354
Lauterbourg 285
Moscow 282
Beijing 280
Nanjing 244
Seoul 240
Altamura 221
São Paulo 207
Lawrence 201
Dong Ket 191
Hefei 166
Buffalo 137
Helsinki 127
Andover 108
San Diego 102
Boardman 99
Columbus 96
Haiphong 93
London 90
Da Nang 88
Jakarta 87
Phoenix 74
Rio de Janeiro 74
Figino 73
Shanghai 73
Turin 73
Atlanta 72
Orem 72
Brooklyn 70
Guangzhou 70
Bologna 63
Naples 63
Munich 62
Nuremberg 61
Changsha 59
Philadelphia 56
Baghdad 55
Ha Long 54
Shenyang 54
Nanchang 53
Tokyo 53
Hebei 52
Montreal 51
Salt Lake City 50
Tianjin 49
Biên Hòa 48
Florence 48
Ninh Bình 48
Curitiba 46
Denver 46
Ottawa 46
Jinan 42
North Bergen 42
San José 42
Jiaxing 41
Can Tho 40
Johannesburg 40
Brasília 38
Hải Dương 38
Palermo 38
Quận Bình Thạnh 37
Tashkent 37
Mexico City 36
Mumbai 35
Jeddah 34
Thái Nguyên 34
Falls Church 33
Verona 33
Warsaw 32
Washington 32
Lahore 31
Miami 30
Totale 35.558
Nome #
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 841
Triage and Evaluation of Potential Safety Signals Identified from Electronic Healthcare Record Databases 744
Burden of Stroke in Europe: An Analysis of the Global Burden of Disease Study Findings from 2010 to 2019 602
Intervention studies in drug utilisation research 591
Epidemiology of SLE in Italy: an observational study using a primary care database 589
Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project 566
Costs and effects of cardiovascular risk reclassification using the ankle-brachial index (ABI) in addition to the Framingham risk scoring in women 509
Magnitude and time-course of excess mortality during COVID-19 outbreak: population-based empirical evidence from highly impacted provinces in northern Italy 431
Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis 420
Trends in cardiovascular diseases burden and vascular risk factors in Italy: The Global Burden of Disease study 1990–2017 414
Valutazione del controllo della malattia da reflusso gastroesofageo in Medicina Generale attraverso l’utilizzo del questionario “GERD Impact scale” 413
Incidence and risk factors for falls among nursing home residents in Italy: a retrospective cohort study 410
Use of computerised general practice database for epidemiological studies in italy: a comparative study with the official national statistics 397
Occupational exposure in the lombardy region (Italy) to sars-cov-2 infection: Results from the mustang–occupation–covid-19 study 389
Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019 347
Azithromycin use and outcomes in patients with COVID-19: an observational real-world study 323
User-only design to assess drug effectiveness in clinical practice: application to bisphosphonates and secondary prevention of fractures 307
Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with Inhibitors 303
Farmacoutilizzazione della terapia per la gestione del paziente con tremore essenziale: uno studio di coorte retrospettivo condotto utilizzando i database dei medici di medicina generale di Regno unito e Francia 299
Discontinuity and failures of therapy with bisphosphonates: Joint assessment of predictors with multi-state models 295
Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database 293
Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019 291
Treatment patterns in essential tremor: Real-world evidence from a United Kingdom and France primary care database 289
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 286
COVID-19 outbreak impact on anticoagulants utilization: an interrupted time-series analysis using healthcare administrative databases 284
Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection 281
The role of electronic healthcare record databases in paediatric drug safety surveillance: A retrospective cohort study 281
Harmonisation of Outcome Estraction for Hearth Failure across Data Sources in the SAFEGUARD Project 275
Risk of severe upper gastrointestinal complications among oral bisphosphonate users 273
Il carico di malattia associato ai virus dell'epatite B e C in Europa. Dati dal Global Burden of Disease Study 2019 270
Azithromycin use and covid-19: a real-world observational study. 266
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study 263
Prescribing pattern of antipsychotic drugs during the years 1996–2010: a population-based database study in Europe with a focus on torsadogenic drugs 262
COVID-19 e suicidio: uno studio retrospettivo sul territorio di Bergamo e provincia 258
Oral bisphosphonates do not increase the risk of severe upper gastrointestinal complications: a nested case-control study 256
Effectiveness of oral bisphosphonates for primary prevention of osteoporotic fractures: evidence from the AIFA-BEST observational study 252
Risk of atrial fibrillation among bisphosphonate users: a multicenter, population-based, Italian study 251
Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression 250
Patterns and trends of idarucizumab use in an Italian region: a probabilistic record-linkage approach in a real-life setting 246
Antidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis 246
A Multicentric Prospective Incidence Study of Guillain-Barre Syndrome in Italy. the ITANG Study 245
Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients 244
Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study 243
Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project 243
Cardiovascular diseases burden in Italy, 1990–2017: the Global Burden of Disease Study 243
Using real-world healthcare data for pharmacovigilance signal detection-the experience of the EU-ADR project 242
Antibiotic-Induced Liver Injury in Paediatric Outpatients: A Case-Control Study in Primary Care Databases 239
Risk of Upper Gastrointestinal Bleeding From Different Drug Combinations 238
The Value of Tucatinib in Metastatic HER2-Positive Breast Cancer Patients: An Italian Cost-Effectiveness Analysis 236
Effects of a computerized decision support system in improving pharmacological management in high-risk cardiovascular patients: A cluster-randomized open-label controlled trial 234
Chronic disease prevalence from Italian administrative databases in the VALORE project: a validation through comparison of population estimates with general practice databases and national survey 233
EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection 231
Identification of acute myocardial infarction from electronic healthcare records using different disease coding systems: a validation study in three European countries 231
Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice? 229
Assessing the risk of osteonecrosis of the jaw (onj) due to bisphosphonates (bp) therapy in the secondary prevention of osteoporotic fractures 228
Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs 227
Food deprivation increases brain nitric oxide synthase and depresses brain serotonin levels in rats 227
Immeasurable time bias nello studio dell'associazione tra utilizzo di bifosfonati orali e rischio di sanguinamento gastrointestinale. 226
Idiopathic Acute Liver Injury in Paediatric Outpatients: Incidence and Signal Detection in Two European Countries 225
Automatic identification of type 2 diabetes, hypertension, ischaemic heart disease, heart failure and their levels of severity from Italian General Practitioners' electronic medical records: A validation study 225
Screening of older community-dwelling people at risk for death and hospitalization: The assistenza socio-sanitaria in italia project 225
Use of azithromycin and risk of ventricular arrhythmia 223
Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks and public health considerations 223
'Use of antipsychotics in children and adolescents: A picture from the ARITMO population-based European cohort study' 222
Need and disparities in primary care management of patients with diabetes 222
Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: Data from the Italian AIFA Anti-diabetics Monitoring Registry 221
Suboptimal Gastroprotective Coverage of NSAID Use and the Risk of Upper Gastrointestinal Complications 220
Signal detection of potentially drug-induced acute liver injury in children using a multi-country healthcare database network 219
Association between azithromycin use and clinical outcomes in COVID-19 patients: an Italian observational study 218
Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: A retrospective cohort study in primary care 218
Valutazione dell’impatto della pandemia sugli accessi al sistema sanitario nei territori di Bergamo e Brescia 215
Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures 215
Systemic antibiotic prescribing to paediatric outpatients in 5 European countries: a population-based cohort study 215
Mediation by nitric oxide formation in the preoptic area of endotoxin and tumour necrosis factor-induced inhibition of water intake in the rat 214
Workshop: Indicatori di appropriatezza prescrittiva a sostegno delle politiche sanitarie. Relazione: Valutazione dell’impatto di programmi di minimizzazione del rischio: principi pratici e applicabilità degli indicatori di appropriatezza 214
Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study 213
Harmonisation of the Event Identification Process in Eight European Healthcare Databases: the experience from the EU-ADR Project. 212
The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease 212
Glossitis, stomatitis, and black tongue with lansoprazole plus clarithromycin and other antibiotics 211
Development and Validation of a Score for Adjusting Health Care Costs in General Practice 210
Patterns and trends of idarucizumab use in an Italian region: A probabilistic record-linkage approach in a real-life setting 208
Risk management and drug utilization research 206
Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: A population-based study 205
Uso degli antidepressivi in Italia: un’analisi nel contesto della Medicina Generale 203
Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal - a 617 400-patient study 203
Chair sessione: storia della sanita’ pubblica II 203
A national survey of the management of atrial fibrillation with antithrombotic drugs in Italian primary care 201
Drug-Induced Acute Myocardial Infarction: Identifying 'Prime Suspects' from Electronic Healthcare Records-Based Surveillance System 201
A cross-sectional survey on benzodiazepine use among older people in an Italian region 198
Pattern of antimicrobial drug prescribing and prescriptive behaviour for acute otitis media among physicians in Sicily 198
Replication of the OMOP Experiment in Europe: Evaluating Methods for Risk Identification in Electronic Health Record Databases 197
Valutazione della prognosi nei soggetti ospedalizzati con COVID-19 in relazione all’utilizzo pregresso di statine: uno studio osservazionale condotto nelle ATS di Bergamo e Brescia 196
Using electronic health care records for drug safety signal detection: A comparative evaluation of statistical methods 196
Risk of cardiac valve regurgitation with dopamine agonist use in parkinsons disease and hyperprolactinaemia: A multi-country, nested case-control study 195
Electronic healthcare databases for active drug safety surveillance: is there enough leverage? 194
Le analisi dei profili prescrittivi dei medici di medicina generale del campione Health Search relative ad alcune condizioni cliniche 194
Hypertension in dialysis patients 192
Drug-induced progressive multifocal leukoencephalopathy in multiple sclerosis: European regulators' perspective 191
Prescribing pattern of antipsychotic drugs in the Italian general population 2000-2005: A focus on elderly with dementia 190
Is suboptimal prescribing a risk factor for poor health outcomes in community-dwelling elders? The ICARe Dicomano study 190
Totale 27.555
Categoria #
all - tutte 206.476
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 206.476


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.500 0 0 0 165 116 176 128 130 111 76 119 479
2022/20233.413 673 917 287 176 165 628 37 130 220 56 74 50
2023/20243.459 64 116 115 118 556 836 659 94 530 82 76 213
2024/20259.562 509 1.508 450 403 820 226 302 246 1.348 1.180 936 1.634
2025/202620.897 2.285 1.925 1.531 1.955 1.594 913 2.445 1.043 1.614 1.500 2.299 1.793
2026/20278.819 771 1.216 2.983 3.849 0 0 0 0 0 0 0 0
Totale 59.677